I
1.85
0.03 (1.65%)
| 前收盘价格 | 1.82 |
| 收盘价格 | 1.86 |
| 成交量 | 220,486 |
| 平均成交量 (3个月) | 332,844 |
| 市值 | 592,147,328 |
| 价格/销量 (P/S) | 1.37 |
| 股市价格/股市净资产 (P/B) | 36.04 |
| 52周波幅 | |
| 利润日期 | 29 Jul 2025 - 4 Aug 2025 |
| 营业利益率 (TTM) | -1,492.81% |
| 稀释每股收益 (EPS TTM) | -0.200 |
| 季度收入增长率 (YOY) | 32.40% |
| 流动比率 (MRQ) | 7.79 |
| 营业现金流 (OCF TTM) | -15.57 M |
| 杠杆自由现金流 (LFCF TTM) | -10.41 M |
| 资产报酬率 (ROA TTM) | -68.06% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (AU) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | IMRICOR CDI FORUS [IMR] | - | - |
AIStockmoo 评分
-0.1
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -3.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.13 |
|
Imricor Medical Systems Inc is a medical device company that develops MRI-guided technology to address issues with traditional X-ray ablation procedures. Its principal business activities are designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The company's products include the Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode. Geographically, the company generates maximum revenue from Europe, followed by the Middle East and the United States. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 内部持股比例 | 17.05% |
| 机构持股比例 | 19.54% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合